Low grade non-muscle invasive bladder cancer
Showing 26 - 50 of >10,000
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
Recruiting
- Urothelial Carcinoma
- +2 more
-
Recife, Pernambuco, Brazil
- +6 more
Jul 11, 2023
Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- BCG combined with Tislelizumab
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Oct 12, 2022
Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing
Not yet recruiting
- Non-Muscle Invasive Bladder Cancer
- +4 more
- Behavioral: Motivational Interviewing with WhatsApp video call
-
Istanbul, Turkeyİrem Nur Ozdemir
Jan 20, 2023
Analytical Specificity of Bladder EpiCheck Test in Healthy
Completed
- Non Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- Bladder EpiCheck
-
San Antonio, TexasUrology San Antonio
Sep 3, 2023
Sensitivity of Multiparametric MRI in Differentiation Between
Recruiting
- Cancer, Bladder
- multiparametric MRI on the bladder
- diagnostic cystoscopy +/- TURBT
-
Badr, Cairo, EgyptFaculty of medicine, Helwan university
Jun 26, 2022
Urine-based Molecular Testing vs Cystoscopy for Surveillance of
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- +2 more
- CxBladder Monitor
- Cystoscopy
-
Scottsdale, Arizona
- +2 more
Nov 14, 2023
Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)
Not yet recruiting
- Non-Muscle Invasive Bladder Cancer
- HER2
- (no location specified)
Jul 16, 2023
Non-muscle Invasive Bladder Cancer Trial in Hanover, Mount Laurel, Rochester (TARA-002)
Recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
-
Los Angeles, California
- +11 more
Jan 31, 2023
Bladder Cancer Trial in Houston (Bladder tumor biopsy)
Recruiting
- Bladder Cancer
- Bladder tumor biopsy
-
Houston, TexasBaylor College of Medicine
Jan 14, 2022
Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)
Active, not recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine 1000 mg, Docetaxel 37.5g
-
Zagreb, CroatiaUniversity Hospital Centre Zagreb
Jan 20, 2023
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle
Recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Lymphadenectomy
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)
Recruiting
- Non-muscle-invasive Bladder Cancer
-
Cairo, EgyptMohamed Fawzy Salman
Nov 19, 2022
Bladder Cancer Recurrent, Non-Invasive Bladder Urothelial Carcinoma Trial in Ankara, Istanbul, Izmir
Recruiting
- Bladder Cancer Recurrent
- Non-Invasive Bladder Urothelial Carcinoma
-
Ankara, Turkey
- +2 more
Apr 10, 2022
Bladder Cancer, Non-muscle Invasive Trial in Biel (Epirubicin, Mitomycin, Gemcitabine)
Recruiting
- Bladder Cancer
- Non-muscle Invasive
- Epirubicin
- +3 more
-
Biel, SwitzerlandRoland Seiler
Nov 17, 2022
Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)
Not yet recruiting
- Muscle Invasive Bladder Urothelial Carcinoma
- Daily Adaptive External Beam Radiation Therapy
-
Saint Louis, MissouriWashington University, St. Louis
Jan 17, 2023
Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)
Recruiting
- Non-Muscle Invasive Bladder Cancer
- Bicalutamide
- Control Arm
-
Québec, CanadaCHU de Québec-Université Laval
Jul 13, 2022
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Bacillus Calmette Guerin With Use of Different Types of Urinary
Completed
- Non-muscle-invasive Bladder Cancer
-
Marathon, Attica, GreeceThemistoklis Bellos
Jan 10, 2023
Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)
Completed
- Bladder Cancer
- intravesical mitomycin-C 40mg/20ml instillation
-
Goyang, Korea, Republic ofNational Cancer Center
Jan 30, 2023
Predicting Post-cystectomy Outcome in Muscle Invasive Bladder
Recruiting
- Bladder Cancer
- develop and validate a deep learning radiomics model based on preoperative enhanced CT image
-
Chongqing, Chongqing, ChinaDepartment of Urology, The First Affiliated Hospital of Chongqin
Oct 18, 2023
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best
Not yet recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Best Practice
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 18, 2023
Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy
Recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- cisplatin based neoadjuvant chemotherapy
- Radical cystectomy alone
-
Rome, ItalyRiccardo Mastroianni
Mar 8, 2023
Bladder Cancer Trial in Tianjin (Cadonilimab)
Recruiting
- Bladder Cancer
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 23, 2023